Cargando…

Oral treatment with PD-0200347, an α(2)δ ligand, reduces the development of experimental osteoarthritis by inhibiting the chondrocytes metalloproteases and inducible nitric oxide synthase gene expression and synthesis

Detalles Bibliográficos
Autores principales: Boileau, C, Martel-Pelletier, J, Brunet, J, Tardif, G, Schrier, D, Flory, C, Boily, M, Pelletier, J-P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833517/
http://dx.doi.org/10.1186/ar1387